undamentalytics Newsletter

Traws Pharma vs Therapeuticsmd

Traws Pharma and Therapeuticsmd are similar in size: $2.8m and $3.0m of revenue in their latest fiscal years. Traws Pharma grew faster (1134.5% against 71.6%). Traws Pharma kept more of each dollar of sales as profit: a net margin of 328.7% against -18.8%.

Latest fiscal yearTraws PharmaTRAW, 2025TherapeuticsmdTXMD, 2025
Revenue $2.8m $3.0m
Revenue growth 1134.5% 71.6%
Net income $9.2m −$569,000
Operating margin -640.7% -145.3%
Net margin 328.7% -18.8%
Return on equity — -2.1%
Free cash flow −$20.8m $2.5m
Cash $3.8m $7.5m
Total debt $0 $0
Debt to equity — 0.0%
Dividend per share — —
Dividend yield — —
Share buybacks — —
Employees — —
Market value $4.6m $20.9m
Price vs our value range — —
Moat score 12 (Weak) 22 (Weak)
Insider trades, 12 months 1 buys, 0 sales 1 buys, 0 sales

Each figure is from the company's latest annual report and links to the page it comes from. Fiscal years can end on different dates. Market value and the value verdict use the delayed price shown on the stock pages. Not a recommendation.

Go deeper

Figures from each company's latest annual report filed with the SEC (10-K or 20-F), as reported, with the fiscal year shown. Not investment advice. How we read filings: methodology.